Inventor · disambiguated record
Julia Hrakovsky
Also filed as: HRAKOVSKY JULIA
7 granted patents·24 pending applications·57 citations·filing 2002–2022
83Inventor score
Files withTEVA PHARMA12HRAKOVSKY JULIA8CONSEJO SUPERIOR INVESTIGACION2ZALIT ILAN2BOROCHOVITCH RONEN1
Top patents by PatentIndex Score
31 records- 0186US6764997B2Stabilized azithromycin compositionsTEVA PHARMA·Filed 2002·Granted Jul 20, 2004·29 cites·59 claims
- 0283US6897340B2Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMA·Filed 2003·Granted May 24, 2005·11 cites·39 claims
- 0382US7749536B2Pharmaceutical formulations of aliphatic amine polymers and methods for their manufactureTEVA PHARMA·Filed 2006·Granted Jul 6, 2010·8 cites·26 claims
- 0480US8865722B2Wet formulations of aripiprazoleHRAKOVSKY JULIA·Filed 2006·Granted Oct 21, 2014·3 cites·22 claims
- 0578US9186333B2Process for preparing pharmaceutical compositions of fingolimodHRAKOVSKY JULIA·Filed 2012·Granted Nov 17, 2015·3 cites·51 claims
- 0677US7572641B2Pharmaceutical compositions comprising meloxicam and methods of their preparationTEVA PHARMA·Filed 2005·Granted Aug 11, 2009·3 cites·21 claims
- 0771US12419838B2Pharmaceutical formulation with improved solubility and bioavailabilityCONSEJO SUPERIOR INVESTIGACION·Filed 2022·Granted Sep 23, 2025·0 cites·3 claims
- 0859US2011086102A1Delayed release compositionsTEVA PHARMA·Filed 2009·Application pending·0 cites
- 0959US2008161607A1Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMA·Filed 2008·Application pending·0 cites
- 1058US2005106239A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 1157US2008058404A1Stable pharmaceutical compositions of 2-aza-bicyclo [3.3.0]-octane-3-carboxylic acid derivativesTEVA PHARMA·Filed 2007·Application pending·0 cites
- 1257US2004192622A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 1357US2007154545A1Dry formulations of aripiprazoleHRAKOVSKY JULIA·Filed 2006·Application pending·0 cites
- 1456US2007213404A1Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMACEUTICAL USA INC·Filed 2007·Application pending·0 cites
- 1555US2013344146A1Dry formulations of aripiprazoleHRAKOVSKY JULIA·Filed 2013·Application pending·0 cites
- 1654US2021267898A1Pharmaceutical Formulation with Improved Solubility and BioavailabilityCONSEJO SUPERIOR INVESTIGACION·Filed 2019·Application pending·0 cites
- 1752US2005069586A1Stable pharmaceutical compositions of 2-aza-bicyclo [3.3.0]-octane-3-carboxylic acid derivativesFiled 2004·Application pending·0 cites
- 1852US2005209342A1Processes for preparation of polymorphic form II of sertraline hydrochlorideBOROCHOVITCH RONEN·Filed 2005·Application pending·0 cites
- 1952US2007184101A1Stable pharmaceutical formulations of montelukast sodiumTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2051US2006188569A1Stable pharmaceutical formulations of zonisamide and methods for their manufactureTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2149US2007014864A1Novel pharmaceutical granulateTEVA PHARMA·Filed 2005·Application pending·0 cites
- 2249US2008149521A9Methods of stabilizing azithromycinPESACHOVICH MICHAEL·Filed 2006·Application pending·0 cites
- 2348US2007184108A1Stable pharmaceutical formulations of montelukast sodiumHRAKOVSKY JULIA·Filed 2006·Application pending·0 cites
- 2446US2006198895A1Azithromycin powder for oral suspension compositionsKOTLIAR ELEONORA M·Filed 2005·Application pending·0 cites
- 2543US2010120848A1Stable pharmaceutical formulations of montelukast sodiumTEVA PHARMA·Filed 2010·Application pending·0 cites
- 2642US2007014854A1Novel granulation processZALIT ILAN·Filed 2005·Application pending·0 cites
- 2742US2007014853A1Pharmaceutical dosage form containing novel pharmaceutical granulateZALIT ILAN·Filed 2005·Application pending·0 cites
- 2841US2008015188A1Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivativesHRAKOVSKY JULIA·Filed 2007·Application pending·0 cites
- 2940US2016199396A1Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavirTEVA PHARMA·Filed 2016·Application pending·0 cites
- 3039US2008008752A1Pharmaceutical compositions of memantineHRAKOVSKY JULIA·Filed 2006·Application pending·0 cites
- 3138US2007172521A1Levetiracetam formulations and methods for their manufactureHRAKOVSKY JULIA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julia Hrakovsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →